Tetra Tech director exercises options for 2,300 shares
TETRA TECH INC director Kirsten M. Volpi exercised stock options covering 2,300 shares of common stock at $9.59 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
TETRA TECH INC director Kirsten M. Volpi exercised stock options covering 2,300 shares of common stock at $9.59 per share. The option exercise converted derivative securities into common stock, leaving her with 74,218 common shares held directly and 4,000 stock options remaining outstanding.
Insider Trade Summary
2,300 shares exercised/converted
Exercise
2 txns
Insider
Volpi Kirsten M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | STOCK OPTION (RIGHT TO BUY) F1 | 2,300 | $0.00 | $0.00 |
| Exercise | COMMON STOCK | 2,300 | $9.59 | $22K |
Holdings After Transaction:
STOCK OPTION (RIGHT TO BUY) — 4,000 contracts (Direct);
COMMON STOCK — 74,218 shares (Direct)
Holdings Before and After:
STOCK OPTION (RIGHT TO BUY), 6,300 to 4,000 contracts (Direct);
COMMON STOCK, 71,918 to 74,218 shares (Direct)
Footnotes (1)
- F1. The option becomes exercisable as to 100% of the shares on the anniversary of the grant date.
Key Figures
Options exercised: 2,300 shares
Exercise price: $9.59 per share
Common shares held: 74,218 shares
+2 more
5 metrics
Options exercised
2,300 shares
Stock options converted into common stock on 2026-08-04
Exercise price
$9.59 per share
Exercise price for 2,300 stock options exercised by the director
Common shares held
74,218 shares
Direct common stock ownership following the reported transactions on 2026-08-04
Options remaining
4,000 shares
Stock options outstanding after exercising 2,300 options
Option expiration
2027-11-18
Expiration date of the reported stock option grant
Key Terms
STOCK OPTION (RIGHT TO BUY), derivative security, direct or indirect
3 terms
STOCK OPTION (RIGHT TO BUY) financial
"Reported security title: STOCK OPTION (RIGHT TO BUY)"
derivative security financial
"Transaction code M described as Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
direct or indirect financial
"Field direct_or_indirect indicates D for direct or I for indirect ownership type"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TTEK director Kirsten M. Volpi report on this Form 4?
Kirsten M. Volpi reported exercising stock options for 2,300 shares of Tetra Tech common stock at $9.59 per share, converting derivative options into shares and updating her reported ownership position.
What was the size and exercise price of the TTEK stock options exercised by Kirsten M. Volpi?
Kirsten M. Volpi exercised stock options covering 2,300 shares of Tetra Tech common stock at an exercise price of $9.59 per share, as reported in the Form 4 insider transaction details.
Did the TTEK Form 4 for Kirsten M. Volpi report any open-market sales of common stock?
No open-market sales were reported. The Form 4 shows an option exercise converting derivative securities into 2,300 common shares, with no transaction coded as a sale of Tetra Tech common stock.
How many TTEK stock options does Kirsten M. Volpi retain after this Form 4, and when do they expire?
Following the reported exercise, Kirsten M. Volpi retains 4,000 stock options on Tetra Tech shares, with the option grant reported as having an expiration date of 2027-11-18 in the transaction data.
What does the footnote on Kirsten M. Volpi’s TTEK stock option grant explain?
The footnote states that the option becomes exercisable as to 100% of the shares on the anniversary of the grant date, clarifying the vesting terms associated with the reported Tetra Tech stock option award.
AI-generated analysis. How Rhea-AI works. Not financial advice.
